These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35113250)
21. Overexpression of matrix metalloproteinase-1 (MMP-1) and MMP-3 in superior limbic keratoconjunctivitis. Sun YC; Hsiao CH; Chen WL; Hu FR Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3701-5. PubMed ID: 21357403 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis. Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013 [TBL] [Abstract][Full Text] [Related]
23. Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva. Udell IJ; Kenyon KR; Sawa M; Dohlman CH Ophthalmology; 1986 Feb; 93(2):162-6. PubMed ID: 3951822 [TBL] [Abstract][Full Text] [Related]
24. Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis. Shen YC; Wang CY; Tsai HY; Lee YF Cornea; 2007 May; 26(4):423-6. PubMed ID: 17457190 [TBL] [Abstract][Full Text] [Related]
25. Use of pressure patching and soft contact lenses in superior limbic keratoconjunctivitis. Mondino BJ; Zaidman GW; Salamon SW Arch Ophthalmol; 1982 Dec; 100(12):1932-4. PubMed ID: 7150059 [TBL] [Abstract][Full Text] [Related]
26. Topical steroids to the superior bulbar conjunctiva for the treatment of superior limbic keratoconjunctivitis (SLK). Kiser KA; Hong AR; Lubniewski A; Huang AJW; Margolis TP Ocul Surf; 2022 Jan; 23():114-115. PubMed ID: 34883275 [No Abstract] [Full Text] [Related]
27. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Goto E; Shimmura S; Shimazaki J; Tsubota K Cornea; 2001 Nov; 20(8):807-10. PubMed ID: 11685056 [TBL] [Abstract][Full Text] [Related]
28. Liquid nitrogen cryotherapy of superior limbic keratoconjunctivitis. Fraunfelder FW Am J Ophthalmol; 2009 Feb; 147(2):234-238.e1. PubMed ID: 18835475 [TBL] [Abstract][Full Text] [Related]
29. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis. Perry HD; Doshi-Carnevale S; Donnenfeld ED; Kornstein HS Ophthalmology; 2003 Aug; 110(8):1578-81. PubMed ID: 12917176 [TBL] [Abstract][Full Text] [Related]
30. The fine structure of nuclear changes in superior limbic keratoconjunctivitis. Collin HB; Donshik PC; Boruchoff SA; Foster CS; Cavanagh HD Invest Ophthalmol Vis Sci; 1978 Jan; 17(1):79-84. PubMed ID: 621134 [TBL] [Abstract][Full Text] [Related]
31. Conjunctival resection with and without amniotic membrane graft for the treatment of superior limbic keratoconjunctivitis. Gris O; Plazas A; Lerma E; Güell JL; Pelegrín L; Elíes D Cornea; 2010 Sep; 29(9):1025-30. PubMed ID: 20539210 [TBL] [Abstract][Full Text] [Related]
32. Treatment of superior limbic keratoconjunctivitis with a large-diameter contact lens and Botulium Toxin A. Chun YS; Kim JC Cornea; 2009 Aug; 28(7):752-8. PubMed ID: 19574913 [TBL] [Abstract][Full Text] [Related]
33. High Inflammatory Infiltrate Correlates With Poor Symptomatic Improvement After Surgical Treatment for Superior Limbic Keratoconjunctivitis. Zoroquiain P; Sanft DM; Esposito E; Cheema D; Dias AB; Burnier MN Cornea; 2018 Apr; 37(4):495-500. PubMed ID: 29346129 [TBL] [Abstract][Full Text] [Related]
34. Superior limbic keratoconjunctivitis in association with scarring of the superior tarsal conjunctiva. Raber IM Cornea; 1996 May; 15(3):312-6. PubMed ID: 8713936 [TBL] [Abstract][Full Text] [Related]
35. Ocular surface squamous neoplasia masquerading as superior limbic keratoconjunctivitis. Moshirfar M; Khalifa YM; Kuo A; Davis D; Mamalis N Middle East Afr J Ophthalmol; 2011 Jan; 18(1):74-6. PubMed ID: 21572741 [TBL] [Abstract][Full Text] [Related]
36. Lacrimal occlusion therapy for the treatment of superior limbic keratoconjunctivitis. Kabat AG Optom Vis Sci; 1998 Oct; 75(10):714-8. PubMed ID: 9798210 [TBL] [Abstract][Full Text] [Related]
37. Immunological aspects of superior limbic keratoconjunctivitis. Eiferman RA; Wilkins EL Can J Ophthalmol; 1979 Apr; 14(2):85-7. PubMed ID: 378334 [TBL] [Abstract][Full Text] [Related]
38. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up. Sahin A; Bozkurt B; Irkec M Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575 [TBL] [Abstract][Full Text] [Related]
39. Extensive superior limbic keratoconjunctivitis in Graves' disease: case report and mini-review of the literature. Chelala E; El Rami H; Dirani A; Fakhoury H; Fadlallah A Clin Ophthalmol; 2015; 9():467-8. PubMed ID: 25792798 [TBL] [Abstract][Full Text] [Related]
40. Conjunctival resection treatment and ultrastructural histopathology of superior limbic keratoconjunctivitis. Donshik PC; Collin HB; Foster CS; Cavanagh HD; Boruchoff SA Am J Ophthalmol; 1978 Jan; 85(1):101-10. PubMed ID: 619676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]